Research Topics
| J Eileen HaySummaryAffiliation: Mayo Clinic Country: USA Publications
| Collaborators
|
Detail Information
Publications
Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?J E Hay
Mayo Clinic, Rochester, MN, USA
Liver Transpl Surg 4:S9-17. 1998..Liver transplantation is the only definitive therapy for primary biliary cirrhosis and primary sclerosing cholangitis...- A controlled trial of calcitonin therapy for the prevention of post-liver transplantation atraumatic fractures in patients with primary biliary cirrhosis and primary sclerosing cholangitisJ E Hay
Division of Gastroenterology, Mayo Medical Center, Rochester, MN 55905, USA
J Hepatol 34:292-8. 2001.... - How effective is bisphosphonate treatment for preventing bone fractures after liver transplantation?J Eileen Hay
Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Nat Clin Pract Gastroenterol Hepatol 5:190-1. 2008 
Liver disease in pregnancyJ Eileen Hay
Division of Gastroenterology and Hepatology, The Mayo Clinic, Rochester, MN, USA
Hepatology 47:1067-76. 2008..Early diagnosis and immediate delivery are essential for maternal and fetal survival...- Evaluation and management of osteoporosis in liver diseaseJ Eileen Hay
Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street, Southwest, Rochester, MN 55905, USA
Clin Liver Dis 9:747-66, viii. 2005..In addition, for the patient with established osteoporosis, specific therapeutic measures may be justified, despite the lack of adequate randomized trials of these agents in patients with hepatic osteopenia... - Osteoporosis in liver diseases and after liver transplantationJ Eileen Hay
Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
J Hepatol 38:856-65. 2003 - Immunosuppressive and postoperative effects of orthotopic liver transplantation on bone metabolismMaureen M J Guichelaar
Division of Liver Transplantation, Mayo Clinic, Rochester, MN 55905, USA
Liver Transpl 10:638-47. 2004..Other factors important in the recovery of bone metabolism after the early phase of bone loss are recovery of liver and gonadal function and better calcium balance... - Bone histomorphometric changes after liver transplantation for chronic cholestatic liver diseaseMaureen M J Guichelaar
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA
J Bone Miner Res 18:2190-9. 2003..Therefore, despite post-transplant bone loss, by 4 months after OLT, bone metabolism had improved, with increased bone formation and more coupled bone balance, as suggested by hierarchical cluster analysis... - Fractures and avascular necrosis before and after orthotopic liver transplantation: long-term follow-up and predictive factorsMaureen M J Guichelaar
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA
Hepatology 46:1198-207. 2007..Nonetheless, 25% of patients undergoing OLT for chronic cholestatic liver disease still develop de novo fractures after OLT; this situation demands an ongoing search for effective therapeutic agents for these patients... - Bone mineral density before and after OLT: long-term follow-up and predictive factorsMaureen M J Guichelaar
Division of Gastroenterology, Mayo Clinic, Rochester, MN 55905, USA
Liver Transpl 12:1390-402. 2006..Patients transplanted most recently have improved bone mass before OLT, and although bone loss still occurs early after OLT, these patients also have a greater recovery in BMD over the years following OLT... - Osteopenia and osteoporosis in patients with end-stage liver disease caused by hepatitis C and alcoholic liver disease: not just a cholestatic problemElizabeth J Carey
Division of Transplant Medicine, Mayo Clinic, Scottsdale, AZ 55905, USA
Liver Transpl 9:1166-73. 2003..Patients with cirrhosis caused by HCV, ALD, or a combination of both should be screened for osteopenia, especially before OLT... - Bone metabolism in advanced cholestatic liver disease: analysis by bone histomorphometryMaureen M J Guichelaar
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA
Hepatology 36:895-903. 2002.... 
Frequency, clinical presentation, and outcomes of drug-induced liver injury after liver transplantationStepan Sembera
William J von Leibig Transplant Center, Mayo Clinic, Rochester, MN 55905, USA
Liver Transpl 18:803-10. 2012..In conclusion, DILI is a rare yet underrecognized event among LT recipients. The majority of cases are not clinically severe, and they resolve after drug cessation without hepatic retransplantation or death...- Unsuspected primary hepatic angiosarcoma associated with portal vein thrombosis complicating cirrhosisSilvania K Pimentel Cauduro
Von Liebeg Transplantation Center, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
Liver Transpl 8:1080-1. 2002 - Results of a prospective study of acute liver failure at 17 tertiary care centers in the United StatesGeorge Ostapowicz
Department of Medicine, Gold Coast Hospital, 108 Nerang Street, Southport, QLD 4215, Australia
Ann Intern Med 137:947-54. 2002..Apparent cause and coma grade at admission were associated with outcome. Although transplantation may improve patient survival, it was unavailable or unnecessary for most patients... - Influence of high body mass index on outcome in acute liver failureAnna Rutherford
GI Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA
Clin Gastroenterol Hepatol 4:1544-9. 2006..This difference is not explained by weight discrimination in listing patients for transplantation, despite evidence for poorer post-transplant outcomes... - Predictive value of actin-free Gc-globulin in acute liver failureFrank V Schiødt
Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas, TX, USA
Liver Transpl 13:1324-9. 2007..A new enzyme-linked immunosorbent assay for actin-free Gc-globulin provides the same (but not optimal) prognostic information as KCH criteria in a single measurement at admission...